DOI QR코드

DOI QR Code

A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea

  • Oh, Yoon Jung (Department of Internal Medicine, Cheju Halla General Hospital) ;
  • Song, Sung Heon (Department of Internal Medicine, Cheju Halla General Hospital) ;
  • Baik, Seung Hee (Department of Internal Medicine, Cheju Halla General Hospital) ;
  • Lee, Hak Hyun (Department of Internal Medicine, Cheju Halla General Hospital) ;
  • Han, In Mee (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Oh, Dong Hyun (Department of Internal Medicine, Yonsei University College of Medicine)
  • 발행 : 2013.07.01

초록

Acinetobacter baumannii (AB) is a common pathogen found in patients with hospitalacquired pneumonia all over the world. Community-acquired AB pneumonia, however, is very rare and has seldom been reported in Asia-Pacific countries. Community-acquired AB pneumonia has a fulminant course and is associated with a higher mortality than hospital-acquired AB pneumonia. In Korea, no case of fatal community-acquired AB pneumonia has been reported to date. Here, we describe the first fatal case of fulminant community-acquired AB pneumonia in Korea.

키워드

참고문헌

  1. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006;42:692-699. https://doi.org/10.1086/500202
  2. Ong CW, Lye DC, Khoo KL, et al. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology 2009;14:1200-1205. https://doi.org/10.1111/j.1440-1843.2009.01630.x
  3. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 2001;120:1072-1077. https://doi.org/10.1378/chest.120.4.1072
  4. Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002;40:685-686. https://doi.org/10.1128/JCM.40.2.685-686.2002
  5. Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006;129:102-109. https://doi.org/10.1378/chest.129.1.102
  6. Han SH, Na DJ, Yoo YW, et al. A case of probable community acquired Acinetobacter baumannii pneumonia. Tuberc Respir Dis 2007;63:273-277. https://doi.org/10.4046/trd.2007.63.3.273
  7. Song JH; Asian Hospital Acquired Pneumonia Working Group. Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP Working Group. Am J Infect Control 2008;36(4 Suppl):S83-S92. https://doi.org/10.1016/j.ajic.2007.01.015
  8. Anstey NM, Currie BJ, Withnall KM. Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis 1992;14:83-91. https://doi.org/10.1093/clinids/14.1.83
  9. Zeana C, Larson E, Sahni J, Bayuga SJ, Wu F, Della-Latta P. The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir? Infect Control Hosp Epidemiol 2003;24:275-279. https://doi.org/10.1086/502209
  10. Ho PL, Cheng VC, Chu CM. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii. Chest 2009;136:1119-1127. https://doi.org/10.1378/chest.09-0285

피인용 문헌

  1. Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature vol.6, pp.2, 2013, https://doi.org/10.1016/j.phrp.2014.12.006
  2. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis vol.13, pp.5, 2015, https://doi.org/10.1586/14787210.2015.1025055
  3. Pneumonia associated withAcinetobacter baumanniiin a group of minks (Neovison vison) vol.35, pp.3, 2013, https://doi.org/10.1080/01652176.2015.1030714
  4. A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea vol.49, pp.4, 2017, https://doi.org/10.3947/ic.2017.49.4.297
  5. High Proportions of Multidrug-Resistant Acinetobacter spp. Isolates in a District in Western India: A Four-Year Antibiotic Susceptibility Study of Clinical Isolates vol.15, pp.1, 2013, https://doi.org/10.3390/ijerph15010153
  6. An unusual cause of community-acquired pneumonia vol.11, pp.None, 2013, https://doi.org/10.1016/j.idcr.2017.12.010
  7. Seasonal and Temperature-Associated Increase in Community-Onset Acinetobacter baumannii Complex Colonization or Infection vol.38, pp.3, 2013, https://doi.org/10.3343/alm.2018.38.3.266
  8. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa vol.25, pp.2, 2013, https://doi.org/10.1089/mdr.2018.0016
  9. Acinetobacter baumannii as Nosocomial Pathogenic Bacteria vol.34, pp.2, 2019, https://doi.org/10.3103/s0891416819020046
  10. Antibacterial Effects of Peganum harmala Seed Extracts on Drug-resistant Clinical Isolates of Acinetobacter baumannii in North of Iran vol.15, pp.2, 2013, https://doi.org/10.5812/jjnpp.92426
  11. Acinetobacter baumannii Infections in Times of COVID-19 Pandemic vol.10, pp.8, 2013, https://doi.org/10.3390/pathogens10081006